Pharmaceutical Technology, Feb 2, 2008 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology, Feb 2, 2008
Online Exclusive
Designing and Delivering Therapeutic Proteins
By Nusrat Motlekar
An updated book summarizes recent research for formulators and drug-delivery specialists.
Special Report
Clearing the Air on Residual Solvents
By Maribel Rios
USP 467 Residual Solvents will take effect on July 1, 2008. But does the industry understand these specifications—and is it prepared?
Peer-Reviewed Research
Quality Systems for Drugs and Biologics
By Andrew G. Edwards
FDA is modernizing and streamlining current good manufacturing practices. The author examines FDA's evolving approach to quality systems and how a manufacturer can implement a quality system framework.
Ingredients Insider
Charting Dosage-Form Manufacturing
By Patricia Van Arnum
Contract manufacturers expand capabilities in aseptic processing, clinical-trial materials supply, and cytotoxic manufacturing.
Washington Report
Limited Resources, Expanding Imports Challenge Regulators
By Jill Wechsler
The rise in overseas manufacturing undermines FDA oversight of drug quality.
Outsourcing
Global Pharmaceutical Powers
By Jim Miller
Another Asian services provider demonstrates the global nature of pharmaceutical outsourcing.
Agent-In-Place
AIM-less
By Control, a senior compliance officer
If at first the product fails, then inspect, inspect again
Viewpoint
Nanotechnology and the Quest for the Ultimate Drug-Delivery System
By Melgardt M. de Villiers
The author suggests a route for nanotechnology's future in the pharmaceutical industry.
From The Editor
Patents "R" Us
By Michelle Hoffman
Can an overload of patent applications lead to the US' demise as a scientific leader?
PharmTech Talk
You're Telling Us...
By Alexis Pellek
PharmTech's polls feature user feedback on issues facing the pharmaceutical industry.
News
Coming Down the Pike: Sirtuins
By Michelle Hoffman
Text sirtuins are the new kinases, according to a presentation given last month at the JP Healthcare Investors Conference in San Francisco by Sirtis CEO Christoph Westphal.
In the Field
A news roundup for February 2008.
Report from: Europe
By Sean Milmo
A wave of pharmaceutical expansions is expected in Europe this year, surprisingly by Indian companies.
In the Spotlight
In the Spotlight
Jacketed hose provides cleanability; Stopper prevents product waste; Accessories control temperature precisely
Pharma Capsules
Pharma Capsules
Brief pharmaceutical news items for February 2008.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here